Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
559.09
559.17
459.95
661.23
624.81
544.06
456.70
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
559.09
559.17
459.95
661.23
624.81
544.06
456.70
Raw Material Cost
214.07
210.46
211.03
281.25
168.48
179.30
125.87
Purchase of Finished goods
7.60
1.80
7.26
29.92
11.69
10.71
9.19
(Increase) / Decrease In Stocks
-22.13
17.86
34.37
-48.97
24.46
-33.22
37.18
Employee Cost
173.05
149.57
126.48
182.94
156.17
142.32
147.08
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
212.41
199.54
178.77
229.95
187.37
213.59
268.57
Total Expenditure (Excl Depreciation)
585.00
579.23
557.91
675.09
548.17
512.70
587.89
Operating Profit (PBDIT) excl Other Income
-25.91
-20.06
-97.96
-13.86
76.64
31.36
-131.19
Other Income
20.66
25.80
51.66
10.97
9.98
29.69
4.48
Operating Profit (PBDIT)
-5.25
5.74
-46.30
-2.89
86.62
61.05
-126.71
Interest
3.88
3.58
4.44
180.84
185.34
173.98
104.83
Exceptional Items
35.99
36.03
102.66
1,676.21
0.00
-15.40
334.01
Gross Profit (PBDT)
26.86
38.19
51.92
1,492.48
-98.72
-128.33
102.47
Depreciation
34.81
36.71
39.12
43.66
45.60
43.22
54.00
Profit Before Tax
-7.95
1.48
12.80
1,448.82
-144.32
-171.55
48.47
Tax
0.77
2.98
46.55
370.91
1.96
16.64
7.71
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-8.72
-1.50
-33.75
1,077.91
-146.28
-188.19
40.76
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
-1.45
-6.43
-3.24
Net Profit
-8.72
-1.50
-33.75
1,077.91
-147.73
-194.62
37.52
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.08
0.33
0.15
Minority Interest
0.35
0.33
0.00
-0.02
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-8.37
-1.17
-33.75
1,077.89
-147.65
-194.29
37.67
Equity Capital
6.13
6.13
6.13
6.13
6.13
6.13
6.13
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
828.66
835.92
837.48
842.67
-234.82
192.66
0.00
Earnings per share (EPS)
-1.37
-0.19
-5.51
175.84
-24.09
-31.69
6.15
Diluted Earnings per share
-1.37
-0.19
-5.43
175.98
-24.11
-31.72
6.15
Operating Profit Margin (Excl OI)
-4.63%
-3.59%
-21.3%
-2.1%
12.27%
5.76%
-28.73%
Gross Profit Margin
4.8%
6.83%
11.29%
225.71%
-15.8%
-23.59%
22.44%
PAT Margin
-1.56%
-0.27%
-7.34%
163.02%
-23.4%
-34.53%
8.96%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -0.01% vs 21.57% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is -615.38% vs 96.53% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -29.16% vs 79.52% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 8.38% vs -19.37% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
Compare Annual Results Of Panacea Biotec With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
559.09
1,811.58
-1,252.49
-69.14%
Other Operating Income
0.00
0.00
0.00
Total Operating income
559.09
1,811.58
-1,252.49
-69.14%
Raw Material Cost
214.07
999.18
-785.11
-78.58%
Purchase of Finished goods
7.60
207.25
-199.65
-96.33%
(Increase) / Decrease In Stocks
-22.13
-47.12
24.99
53.03%
Employee Cost
173.05
208.91
-35.86
-17.17%
Power Cost
0.00
40.62
-40.62
-100.00%
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
105.25
-105.25
-100.00%
Other Expenses
212.41
123.42
88.99
72.10%
Total Expenditure (Excl Depreciation)
585.00
1,637.51
-1,052.51
-64.28%
Operating Profit (PBDIT) excl Other Income
-25.91
174.07
-199.98
-114.88%
Other Income
20.66
18.36
2.30
12.53%
Operating Profit (PBDIT)
-5.25
192.43
-197.68
-102.73%
Interest
3.88
8.34
-4.46
-53.48%
Exceptional Items
35.99
0.00
35.99
Gross Profit (PBDT)
26.86
184.09
-157.23
-85.41%
Depreciation
34.81
28.98
5.83
20.12%
Profit Before Tax
-7.95
155.11
-163.06
-105.13%
Tax
0.77
37.09
-36.32
-97.92%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-8.72
118.02
-126.74
-107.39%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
-8.72
118.02
-126.74
-107.39%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.35
0.01
0.34
3,400.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-8.37
118.02
-126.39
-107.09%
Equity Capital
6.13
109.58
-103.45
-94.41%
Face Value
1.00
2.00
0.00
Reserves
828.66
1,046.65
-217.99
-20.83%
Earnings per share (EPS)
-1.37
2.15
-3.52
-163.72%
Diluted Earnings per share
-1.37
2.20
-3.57
-162.27%
Operating Profit Margin (Excl OI)
-4.63%
9.61%
0.00
-14.24%
Gross Profit Margin
4.80%
10.16%
0.00
-5.36%
PAT Margin
-1.56%
6.51%
0.00
-8.07%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 559.09 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -0.01% vs 21.57% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit -8.37 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -615.38% vs 96.53% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -25.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -29.16% vs 79.52% in Mar 2024
Annual - Interest
Interest 3.88 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 8.38% vs -19.37% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -4.63%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
